Bilal Sahin

Bilal Sahin

Auto-generated profile, based on publicly available information

Bilal Sahin

Sivas Cumhuriyet University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 August 2022 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
BSBilal Sahin
Bilal Sahin
SKSEBAHATTIN KARABULUT
SEBAHATTIN KARABULUT
AFAhmet Kemal Filiz
Ahmet Kemal Filiz
MÖMustafa Özkaraca
Mustafa Özkaraca
AGArzu Gezer
Arzu Gezer
HAHilmi Ataseven
Hilmi Ataseven

10 April 2022 in Neurological Research
Verified
Journal Article
Closed access
BSBilal Sahin
Bilal Sahin
EOErcan Ozdemir
Ercan Ozdemir
EGErkan Gumus
Erkan Gumus
MEMustafa Ergul
Mustafa Ergul
ATAhmet Sevki Taskiran
Ahmet Sevki Taskiran
Recently, studies have demonstrated that serotonin type 7 receptors (5-HT7) have conflincting effects on neuronal excitability in different brain regions. However, the effect of 5-HT7 on seizures has not been exactly elucidated yet. Therefore, our aim in this study was to investigate the effects of 5-HT7 antagonist SB-269970 on pentylenetetrazole (PTZ) induced fully kindled rats. In the study, 32 adult male Wistar Albino rats (weighing 220–260 g) were used. Rats were injected with PTZ (35 mg/kg) intraperitoneally every other day to generate kindling model. 5-CT (0.1 mg/kg) and SB-269970 (1 mg/kg) were administered 30 min before acute seizure induction with PTZ (35 mg/kg). Seizure stages were determined according to the Racine scale. After electrocorticography (ECoG) recordings of seizure-induced rats were obtained, the animals were sacrificed by decapitation. The hippocampal GABA levels were determined by ELISA kit and the number of c-Fos positive neurons in the hippocampal dentate gyrus (DG), CA1 and CA3 areas were measured by immunohistochemical method. The results showed that SB-269970 reduced the number of spikes, percent seizure duration and duration of generalized tonic-clonic seizures (dGTCS), while increasing the onset time of generalized tonic-clonic seizures (oGTCS). The hippocampal GABA levels were significantly increased in the SB-269970 group compared with the PTZ group. In addition, SB-269970 reduced the number of c-Fos positive cells in hippocampal CA1 area. 5-HT7 antagonist SB-269970 displays anticonvulsant effects on PTZ-induced seizures in fully kindled rats and these effects may be related to GABAergic activity in the hippocampus.

5 January 2026 in Neurological Research
Verified
Journal Article
Closed access
AÇArzuhan çetindağ
Arzuhan çetindağ
BŞBilal Şahin
Bilal Şahin
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
Epilepsy remains a major neurological disorder with high rates of drug resistance and cognitive decline. Repurposing neuroprotective drugs offers a promising approach. Metformin, a widely used antidiabetic agent, has shown anticonvulsant effects, yet its impact on nitric oxide synthase (NOS) isoforms in distinct brain regions remains unclear. Adult male Wistar rats were allocated into control, pentylenetetrazole (PTZ), or metformin+PTZ groups. Metformin (200 mg/kg, i.p.) was administered for 7 days before induction of acute PTZ seizures (45 mg/kg, i.p.). Seizure severity and latency were assessed using Racine's scale, and cognition was evaluated by the passive avoidance test (PAT). Nitric oxide (NO) and the expression of its synthesizing enzymes, inducible (iNOS), neuronal (nNOS), and endothelial (eNOS), were quantified in the cortex and hippocampus via enzyme-linked immunosorbent assay (ELISA). In silico analyses included target prediction and molecular docking to assess metformin - NOS interactions. Metformin significantly reduced seizure severity, prolonged latency to the first myoclonic jerk, and prevented PTZ-induced memory impairment (all p < 0.001). These behavioral effects were accompanied by reductions in cortical and hippocampal nNOS and iNOS expression, decreased cortical eNOS levels, and lower NO accumulation. TargetNet predicted NOS isoforms among potential metformin targets, and docking indicated moderate binding affinity (-5.2 to -5.9 kcal/mol). Metformin exerted seizure-suppressing and cognition-preserving effects in an acute PTZ model, associated with reductions in NOS isoform expression and NO levels, suggesting altered NOS/NO signaling and supporting its potential as an adjunctive candidate for mitigating seizure-related neuronal dysfunction.

1 December 2024 in Neurochemical Journal
Verified
Journal Article
Closed access
PDF file
BSBilal Sahin
Bilal Sahin
HGHandan Günes
Handan Günes
Pantoprazole’s neuroprotective effects and its role in altering processes linked to apoptosis, inflammation, and oxidative stress were demonstrated. Consequently, this study aimed to explore how pantoprazole influences the development of morphine tolerance and the associated mechanisms, including apoptosis, oxidative stress, and inflammation. Six groups of rats were created: saline, 10 mg/kg pantoprazole, 5 mg/kg morphine, morphine tolerance, morphine + pantoprazole, and morphine tolerance + pantoprazole. Hot plate and tail-flick tests were utilized to detect the analgesic effect. Following the analgesic tests, samples of the dorsal root ganglion (DRG) tissues were collected. Oxidative stress parameters (total oxidant status, total antioxidant status), inflammation parameters (Pro-IL-1β, IL-1β, NLRP-3), and apoptosis proteins (Caspase-1, Caspase-3, Capsape-9) were detected in dorsal root ganglions (DRG) tissues. Pantoprazole showed a weak but statistically significant analgesic activity when given alone. Furthermore, pantoprazole potentiated the antinociceptive effect of morphine and prevented the development of tolerance to morphine. Moreover, it increased total antioxidant status and decreased total oxidant status as well as caspase-1 when given with single-dose morphine and after tolerance induction. Furthermore, pantoprazole decreased Pro-IL-1β, IL-1β, Caspase-3 and Capsape-9 levels after tolerance development. Collectively, pantoprazole produces a weak analgesic activity and boosts the morphine’s analgesic effect. On the other hand, pantoprazole can prevent tolerance development. These effects likely arise through the modulation of pathways associated with oxidative stress, inflammation and apoptosis pathways.

29 June 2022 in Türk Doğa ve Fen Dergisi
Verified
Journal Article
Open access
PDF file
BŞBilal Şahi̇n
Bilal Şahi̇n
HGHandan Güneş
Handan Güneş
Bu çalışmanın amacı, sıçanlarda pentilentetrazol (PTZ) ile oluşturulan nöbetlerde diazepamın antikonvulzif etkinliğinde nitrik oksit sentaz (NOS) ve beyin kaynaklı nörotrofik faktör (BDNF) üzerine etkisini araştırmaktır. Çalışmada 24 adet erkek Wistar Albino sıçan kullanılmıştır. Sıçanlar kontrol grubu, salin (1 mL kg-1) + PTZ, diazepam (0,5 mg kg-1) + PTZ ve diazepam (2 mg kg-1)+PTZ grubu olarak 4 gruba ayrılmıştır (n=6). İntraperitoneal ilaç uygulamalarından 24 saat sonra biyokimyasal incelemeler için tüm sıçanların beyin dokuları çıkarılıp, korteks ve hipokampüs bölgeleri ayrılmıştır. Korteks ve hipokampüsteki NOS ve BDNF düzeyleri enzim bağlı immünosorbent analizi (ELISA) kitleri kullanılarak ölçülmüştür. Diazepam, salin+PTZ uygulanan grubuna göre istatistiksel açıdan anlamlı bir şekilde nöbet evresini azalttı ve ilk miyoklonik jerk (İMJ) süresini uzattı (p<0.001). Salin+PTZ, kontrol grubuna kıyasla hipokampüste NOS seviyelerini anlamlı olarak azalttı (p<0.05). Bununla birlikte diazepam+PTZ grupları, salin+PTZ grubuyla karşılaştırıldığında hipokampal NOS seviyesini anlamlı olarak artırdı (p<0.001). Ayrıca,salin+PTZ grubu kontrolle karşılaştırıldığında korteks ve hipokampüste BDNF seviyesini artırırken (p<0.05), diazepam+PTZ uygulanan gruplarda BDNF seviyesi salin+PTZ grubuna kıyasla düşüktü (p<0.001). Diazepam hipokampüste NOS seviyesini artırmış, korteks ve hipokampüste ise BDNF seviyelerini düşürmüştür. Sonuç olarak, diazepamın NOS ve BDNF üzerine regülatif etkisi antikonvulsif etkisiyle ilişkili olabilir.